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Abstract The fluorescence probe, 8-anilino-l-naphthalenesul-
fonic acid (ANS), was used to monitor the induced-fit 
conformational movement in rabbit muscle adenylate kinase. In 
50 mM Tris-HCl buffer (pH 8.1), the time course of ANS 
binding to rabbit muscle adenylate kinase is a biphasic process. 
The fast phase completes within the dead-time of the stopped-
flow equipment used (about 15 ms), while the slow phase ends in 
about 10 minutes. In the presence of 2.0 (iM peptidyl prolyl cisl 
rra/w-isomerase, the rate constant of the slow phase reaction is 
accelerated about 2.4-fold, suggesting that the domain movement 
during ANS binding to rabbit muscle adenylate kinase may 
involve proline isomerization. The activation energy of the slow 
phase was determined to be 74.6 kJ/mol, which is comparable to 
the activation energy of proline cis/frans-isomerization (about 80 
kJ/mol). 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Adenylate kinase (AK, EC 2.7.4.3) catalyzes the phosphoryl 
transfer reaction: MgATP+AMP7 ^ MgADP+ADP [1,2]. 
The enzyme contains two distinct nucleotide-binding sites: 
the MgATP site, which binds MgATP and MgADP, and 
the AMP site, which is specific for AMP and uncomplexed 
ADP [3,4]. Previous studies have suggested that adenylate 
kinase undergoes substrate-induced conformational changes 
to shield the substrate from water by surrounding it with 
catalytic residues, and to prevent the escape of kinetic inter-
mediates [5-7]. X-ray analysis of enzyme crystals revealed that 
the AMP-binding domain undergoes a movement of 8 A upon 
AMP binding and that the ATP-binding domain moves up to 
30 A upon binding with ATP [7,8]. This was strongly sup-
ported by investigations of different ligand forms of AK in 
solution using several methods [9-16]. However, these and 
other published investigations have paid little attention to 
whether these substrate-induced conformational changes in-
volve proline isomerization. 
A well-known property of proline residue is its unique abil-
ity to form cz's-peptide bonds and to undergo cisltrans-isomer-
ization. About 7% of all prolyl peptide bonds are cis in native 
proteins of known three-dimensional structure [17,18]. The 
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equilibrium between cis and ^raws-conformation of an Xaa-
Pro peptide bond induces conformational heterogeneity and 
appears to be widespread in proteins and of importance for 
the biological function of a protein [19]. 
The prolyl isomerization can be catalyzed by peptidyl prolyl 
cw/fra«i*-isomerases (PPIase, EC 5.2.1.8), which were discov-
ered in porcine kidney by Fischer and his co-workers in 1984 
[20]. PPIases not only efficiently catalyze prolyl peptide bond 
isomerizations in oligopeptides, but also accelerate slow, pro-
line-isomerization-limited steps in the folding of numerous 
proteins [21]. 
Two crystal forms, A and B, of adenylate kinase from por-
cine muscle have been reported [3], which are interconvertable 
depending on the pH of the mother liquid. The experiments of 
ANS or ATP soaking with AK revealed that ANS- or ATP-
binding crystal could only be obtained in the case of crystal 
form B. ANS occupies the pocket formed between the [3-sheet, 
loop 16-22, helix 23-30 and the C-terminal helix. This pocket 
was originally assigned to the adenosine moiety of AMP 
site[3], which turned out recently as ATP site [4,22]. ANS 
binds to AK with a dissociation constant, kd, of 56 ±5 mM 
[10-12,23]. The binding of ANS to AK enhances the quantum 
yield of ANS fluorescence as well as shifts the emission peak 
to a shorter wavelength [23]. A previous study in this labora-
tory found that the time course of the fluorescence of ANS 
binding to AK was a biphasic process. The fast phase fluo-
rescence completes within the dead-time of the stopped-flow 
equipment used, whereas the slow phase reaction completes in 
about 10 minutes, which was interpreted to result from the 
conformational changes during AK binding to ANS. Sub-
strates, AMP, ADP and ATP decrease both the fast and 
slow phase fluorescence. The inhibition efficiency is in the 
order of AMP < ADP < ATP. ATP was found to bind com-
petitively with AK respect to ANS, but AMP not. ANS has 
also been found to be an inhibitor of AK for both the fast and 
slow steps [24]. 
Investigation of the fluorescence property of ANS binding 
to AK should develop the understanding of the induced-fit 
conformational changes. The present communication reports 
the effects of PPIase on the slow phase reaction of ANS bind-
ing to AK. The results suggest that the domain movement of 
AK during binding with ANS may involves the proline iso-
merization. 
2. Materials and methods 
2.1. Materials 
Peptide succinyl-Ala-Ala-Pro-Phe-4-nitroanilide was purchased 
from Peptide Institute Inc. in Japan. Chymotrypsin (Type VII: from 
Bovine Pancreas, TLCK treated) was a product of Sigma. Glucose-6-
phosphate dehydrogenase, hexoskinase, NADP and ANS were Sigma 
products. Urea was product of NACALA TESQUE, INC. (Japan). 
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Glucose, Mg acetate and Tris-HCl were local products of analytical 
grade. Tris-HCl buffer was always freshly prepared. 
2.2. Methods 
The porcine 17-kDa PPIase was purified according to the method 
described by Kofron et al. [25]. The enzyme migrates as a single band 
in reducing SDS-PAGE. The prolyl isomerase activity was measured 
using the chromogenic peptide succinyl-Ala-Ala-Pro-Phe-4-nitroani-
lide in a coupled assay with chymotrypsin as reported by Takahashi 
et al. [26]. The assay buffer (855 ul of 35 mM HEPES containing 
5 mM 2-mercaptoethanol, pH 7.8 at 25°C) was equilibrated in the 
spectrometer cell (UV-250) before adding the peptide substrate (stored 
in DMSO, final concentration 42 uM) in the same buffer. Samples 
were equilibrated for 1 min, and then PPIase (10 ul, 0.1-0.2 ug) was 
incubated with the substrate for 30 s. The reaction was then started by 
adding 20 ul 0.76 mM of chymotrypsin (final concentration 15.2 uM). 
The control measurement was performed under the same conditions 
in the absence of PPIase. The formation of p-nitroaniline was fol-
lowed at 360 nm. The trans-isomsr (approximately 90% of equilibrium 
population) of the substrate was consumed by chymotrypsin hydrol-
ysis during the mixing time as indicated by sudden absorbance 
change. Further change represented the rate of cu/fraws-isomerization 
of the peptide substrate. The enzyme concentration was determined by 
using the molar extinction coefficient e2so = 8730 M
_ 1 cm - 1 calculated 
on the basis of aromatic amino acid content [27]. 
Rabbit muscle adenylate kinase was prepared essentially according 
to Zhang et al. [28]. The yield was usually about 60 mg of pure 
enzyme per kg rabbit skeletal muscle. The final preparation usually 
had a specific activity greater than 1600 units/mg and showed only 
one peak in SDS electrophoresis, gel filtration and reversed-phase 
FPLC. One unit is defined as the amount of enzyme catalyzing the 
formation of 1 umol/minute ATP generated from ADP. 
The activity was assayed by following the reduction of NADP in a 
coupled enzyme solution with hexokinase and glucose-6-phosphate 
dehydrogenase. The reaction mixture contained 2.5 mM ADP, 2.1 
mM Mg acetate, 6.7 mM NADP, 20 units hexokinase and 10 units 
glucose-6-phosphate dehydrogenase in 50 mM Tris-HCl buffer (pH 
8.1). The concentration of AK was determined by absorption at 280 
nm with e ? ^ = 0.52. 
The kinetics of ANS binding were measured using a SPF-17 
stopped-flow system with a syringe ratio of 1:1 (Applied Photophysics 
Ltd., UK). One syringe contained a specified concentration of ANS in 
50 mM Tris/HCl containing 1 mM EDTA at pH 8.1, 25°C while the 
other syringe contained appropriate protein samples. The concentra-
tion of adenylate kinase was 4.8 (xM for all experiments unless other-
wise specified. Creatine kinase (CK), prepared as described [29,30], 
was used in the ANS-binding experiment with the same concentration 
as AK as a comparison. The final ANS concentration was 200 uM. 
The ANS concentration was determined using the extinction coeffi-
cient s = 4.85xl03 M _ 1 cm - 1 in aqueous solution. The samples were 
excited at 378 nm and the emission above 410 nm was detected using 
a wavelength cutoff filter. The dead-time in the experiments was about 
15 ms. In all measurements, the baseline was calibrated with ANS 
solution. 
Digitized kinetic traces were analyzed using the software provided 
with the Applied Photophysics Kinetic Spectrometer Workstation 
(Archimedes). Apparent first-order rate constants (k) were obtained 
by non-linear least-squares fits of the data to: 
At = AB{l-exp{-kt)) + Ai 
where At is the total fluorescence intensity measured at time ;, A[ is 
the amplitude of the fast phase reaction (dead-time about 15 ms), Aa 
is the amplitude of the slow phase reaction, and k is the rate constant 
of the slow phase reaction. 
3. Results 
3.1. Effect of PPIase on ANS binding to AK 
The binding kinetics of ANS to AK were measured in the 
presence of 0 to 2.0 uJVi PPIase. Both in the absence and 
presence of PPIase the time courses of ANS binding to AK 
are biphasic process. The fast kinetic phase was unaffected by 
PPIase but the slow binding interaction was accelerated by 
PPIase (Fig. 1A). The time constant (x) of the slow phase 
was reduced from x = 480 s in the absence of PPIase to 
x = 200 s in the presence of 2.0 mM PPIase, equivalent to a 
2.4-fold acceleration. In the control experiment, the time 
course of 2.0 mM PPIase mixed with 200 mM ANS showed 
no evidence of ANS binding to PPIase inducing fluorescence 
changes under our experimental conditions. The dependence 
of the apparent rate constants on the concentration of PPIase 
is shown in Fig. IB. 
3.2. Heat-inactivated PPIase or non-specific proteins have no 
catalysis effect on the kinetics of ANS binding to AK 
To clarify whether the catalysis of AK to ANS binding 
kinetics arises from the biological function of PPIase or 
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Fig. 1. (A) Catalysis of ANS binding kinetics monitored by fluorescence changes in the presence of increasing concentrations of PPIase from 
porcine kidney. The increase in ANS fluorescence excited at 378 nm and the emission above 410 nm is shown as a function of time in 50 mM 
Tris-HCl, pH 8.1, at 25°C in the presence of the indicated concentrations of PPIase. The total fluorescence change during the measurement 
was defined as 100%. (B) The apparent rate constants of ANS fluorescence changes for various PPIase concentrations. The data is presented as 
the ratio of the observed rate constants in the presence, k, and in the absence, ICQ, of PPIase. 
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from the protein effect, the binding kinetics of ANS binding 
to AK were measured in the presence of heat-inactivated 
PPIase. The isomerase activity of PPIase was suppressed irre-
versibly by heat inactivation (30 min at 80°C) [31]. No rate 
enhancement was observed in the presence of 2.0 (iM heat-
inactivated PPIase. 
Creatine kinase (CK) was used to test the unspecified pro-
tein effect, because the fluorescence kinetics of ANS binding 
to CK showed only one fast phase. The fluorescence signal 
nearly overlaid the base line during the entire course of the 
measurement for as long as 1000 s (data not shown). No 
increase in the rate of the slow-binding phase of ANS-AK 
could be detected in the presence of 0.6 \iM CK, thus ruling 
out any unspecified protein effect. These results are shown in 
Fig. 2 for clarity. 
3.3. Activation energy of ANS binding to AK 
The above experiments demonstrated that proline isomer-
ization may be involved in the conformational changes during 
ANS binding to AK. The activation energy of proline cisl 
/raws-isomerization is about 80 kJ/mol [21]. For comparison, 
the activation energy of the conformational changes during 
ANS binding to AK was determined by measuring the tem-
perature dependence of the slow phase rate constant of the 
fluorescence changes during ANS binding to AK at pH 8.1. 
Fig. 3 shows the Arrhenius plot of the rate constant of the 
slow phase of ANS binding to AK versus temperature. The 
apparent activation energy for this reaction was found to be 
74.6 kJ/mol. 
4. Discussion 
ANS is widely used as a hydrophobic probe of protein 
structures. The fluorescence intensity of ANS binding to a 
protein is dependent on the microenvironment of the binding 
site and the solvent environment [32]. AK has one ANS-bind-
ing site around the adenosine moiety of ATP-binding site 
[3,4,22], so that the property of binding ANS to AK can 
represent, at least to some extent, that of binding ATP to 
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Fig. 2. Effect of inactivated PPI or non-specific protein, creatine 
kinase (CK), on ANS-binding kinetics monitored by fluorescence 
changes. Kinetic measurements were carried out as described in 
Fig. 1. 
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Fig. 3. The Arrhenius plot of the rate constants of the ANS binding 
to AK as a function of temperature. Kinetic measurements were 
carried out as described in Fig. 1. 
AK. The fast phase fluorescence should come from the rapid 
combination of the enzyme with the dye, whereas the slow 
phase fluorescence may arise from the conformational changes 
during ANS binding to AK. Our observation that PPI can 
catalyze the slow phase ANS-binding fluorescence suggests 
that the induced-fit domain movement in AK might involve 
proline isomerization. The activation energy of the slow 
phase, which was determined from the temperature depend-
ence of the binding kinetics of ANS to AK to be 74.6 kJ/mol, 
is similar to that of proline isomerization [21] which supports 
our suggestion that a proline isomerization is possibly in-
volved in this process. 
Sequencing and X-ray crystallography results show that 
there are 6 proline residues in rabbit muscle adenylate kinase 
[33]. Three of the proline residues are conserved: one cis-form 
(Pro96) is in the active center while the other two trans-form 
(Pro17 and Pro159) are located at loop 16-22 and alpha-helix 
145-165, respectively. The active center is located in a hydro-
phobic pocket deep in a cleft between two domains. Another 
hydrophobic pocket behind loop 16-22 and helix 23-30 has 
been assigned to the binding site of ATP and ANS [3,4,22]. 
Although it is difficult to distinguish which proline residue 
is involved in the isomerization equilibrium, the following 
evidence suggests that proline 17 might be a likely candidate 
even though it is in trans-form in the native structure of AK. 
1. The existence of Gly16 preceding Pro17 suggests that the 
Gly-Pro sequence could undergo cw/?ra«.y-isomerization. 
Analysis of the protein sequence data bank MIPSX36 
for the fractions of X-Pro bonds in the total pool of 
established sequences [34] clearly demonstrates that cis-
peptide bond occur with the highest frequency when X 
is Tyr, Leu, Ser, Gly, and Phe. Moreover, as reported 
earlier the sequence of loop 16-22 is Gly-Pro-Gly-Ser-
Gly-Lys-Gly, i.e. every second position has a glycine 
residue, which allows for a large range of dihedral an-
gles at their Ca atoms. The glycine-rich sequence has 
now been recognized as a fingerprint sequence for nu-
cleotide-binding sites. Consequently, the conformation 
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of loop 16-22 is so flexible that it could be in one con-
formation with Pro 1 7 in trans-iorm or with Pro 1 7 in cis-
form. 
2. Tagaya et al. [35] characterized two mutants of chicken 
adenylate kinase in which Pro 1 7 was replaced by Gly or 
Val. Their results suggest that Pro 1 7 plays an important 
role for the binding of substrates, but not for catalytic 
efficiency, al though it does not directly interact with 
substrates. It is conceivable that the rigid turn at Pro 1 7 
in the loop structure is important for the binding of the 
substrate nucleotides since the replacement of Pro 1 7 by 
Val would perturb the turn and replacement by Gly 
would make the turn loose. 
3. X-ray diffraction analysis of porcine A K at 4.7 A reso-
lution indicated the existence of three crystalline forms 
depending on the p H of the mother liquor [3]. F o r m A 
exists in p H 6.9-8.0 while form B exists in p H 5.7-6.0. 
An experiment with A N S soaking with A K revealed 
that the ANS-binding crystal could only be obtained 
with crystalline form B [3]. The Gly-rich loop moves 
about 6 A during the transition between two crystalline 
forms. Therefore, form B was more 'open' in structure 
than form A. The ?ra«^-peptide bond between Gly16 and 
Pro 1 7 in crystal form A was deduced from the refined 
structure of porcine A K at 2.1 A resolution [33]. How-
ever, the structure of form B at high resolution is un-
available because of the labile crystal quality [33]. 
The present study provides new information on induced-fit 
movement in adenylate kinase. The proline isomerization in-
volving in induced-fit movement is of importance for under-
standing the biological function of adenylate kinase. 
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